Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 09:32 am Purchase | 2025-03-31 | 13G | Tenaya Therapeutics, Inc. TNYA | Woodline Partners LP | 5,916,167 6.800% | 5,916,167 (New Position) | Filing History |
| 2025-05-14 4:18 pm Unchanged | 2025-05-07 | 13D | Tenaya Therapeutics, Inc. TNYA | The Column Group III, LP | 49,313,559 30.300% | 0 (Unchanged) | Filing History |
| 2025-05-07 09:31 am Purchase | 2025-03-31 | 13G | Tenaya Therapeutics, Inc. TNYA | Empery Asset Management, LP | 8,727,314 9.960% | 8,727,314 (New Position) | Filing History |
| 2025-03-07 8:22 pm Purchase | 2025-03-04 | 13D | Tenaya Therapeutics, Inc. TNYA | Casdin Capital, LLC | 6,732,971 4.300% | 305,771 (+4.76%) | Filing History |
| 2025-03-07 7:50 pm Purchase | 2025-03-05 | 13D | Tenaya Therapeutics, Inc. TNYA | The Column Group III, LP | 49,313,559 32.000% | 35,714,284 (+262.62%) | Filing History |
| 2025-03-06 10:52 am Sale | 2025-02-28 | 13G | Tenaya Therapeutics, Inc. TNYA | JPMORGAN CHASE & CO JPM | 2,283,914 2.800% | -2,871,036 (-55.69%) | Filing History |
| 2025-02-14 6:42 pm Sale | 2024-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | RA Capital Management, L.P. | 0 0.000% | -7,980,736 (Position Closed) | Filing History |
| 2025-02-10 12:51 pm Purchase | 2024-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | JPMORGAN CHASE & CO JPM | 5,154,950 6.500% | 5,154,950 (New Position) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | BlackRock Inc. BLK | 5,296,476 6.700% | 1,509,652 (+39.87%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Tenaya Therapeutics, Inc. TNYA | RA Capital Management, L.P. | 7,980,736 9.990% | 1,032,500 (+14.86%) | Filing History |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | Tenaya Therapeutics, Inc. TNYA | T. Rowe Price Associates, Inc. | 3,028,435 3.800% | -1,516,108 (-33.36%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | RA Capital Management, L.P. | 6,948,236 9.990% | 519,753 (+8.09%) | Filing History |
| 2024-02-14 4:19 pm Purchase | 2024-02-12 | 13D | Tenaya Therapeutics, Inc. TNYA | The Column Group III, LP | 13,599,275 17.700% | 2,229,001 (+19.60%) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | T. Rowe Price Associates, Inc. | 4,544,543 6.700% | 72,341 (+1.62%) | Filing History |
| 2024-02-14 07:29 am Sale | 2023-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | RTW Investments, LP | 0 0.000% | -2,458,750 (Position Closed) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | BlackRock Inc. BLK | 3,786,824 5.600% | 3,786,824 (New Position) | Filing History |
| 2023-02-21 5:26 pm Purchase | 2023-02-08 | 13D | Tenaya Therapeutics, Inc. TNYA | The Column Group III, LP | 11,370,274 17.800% | 1,754,890 (+18.25%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | RA Capital Management, L.P. | 6,428,483 9.990% | 2,876,975 (+81.01%) | Filing History |
| 2023-02-14 12:38 pm Purchase | 2022-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | T. Rowe Price Associates, Inc. | 4,472,202 6.700% | 1,478,699 (+49.40%) | Filing History |
| 2023-02-09 12:39 pm Sale | 2023-02-09 | 13G | Tenaya Therapeutics, Inc. TNYA | FMR LLC | 2,830,476 4.236% | -294,822 (-9.43%) | Filing History |